Literature DB >> 16096703

Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product.

Wei Zhang1, Edgar S L Liu, Jun Fu, Hai-Mei Tian, Ying-Jye Wu, Shiu-Fun Pang.   

Abstract

CKBM is a product composed of natural ingredients and had been shown to possess certain anti-cancer effects in vitro and in vivo. The aim of the present study is to analyze the chemosensitivity in the treatment of primary colon, breast, gastric and bladder cancer cells by CKBM. A total of 77 patients with cancers of breast, colon, stomach or bladder were included in the present study. Primary cancer cells were isolated from the surgical removed tumors and treated with various dosages of CKBM for 5 days. ATP is then extracted and measured by luminescence assay. CKBM treatment inhibited primary colon, breast, gastric and bladder cancer growth dose-dependently. The IC values were smaller from tumor cells at early stages, when compared with the ones at later stages. The present study strongly indicated that CKBM exerted cytotoxic effect on primary cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16096703     DOI: 10.1007/s10637-005-2633-6

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.651


  26 in total

1.  Immunomodulating effects of CKBM on the cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy volunteers.

Authors:  B P Chan; W F Yuen; W H Lee; S N Wong; T Y Chung; Y J Wu; S F Pang
Journal:  Immunopharmacol Immunotoxicol       Date:  2004-05       Impact factor: 2.730

2.  Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene.

Authors:  G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

3.  Anti-cancer and pro-apoptotic effects of an herbal medicine and Saccharomyces cerevisiae product (CKBM) on human hepatocellular carcinoma HepG2 cells in vitro and in vivo.

Authors:  J Y W Chan; J Y N Cheung; S C W Luk; Y J Wu; S F Pang; K P Fung
Journal:  Immunopharmacol Immunotoxicol       Date:  2004       Impact factor: 2.730

4.  Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats.

Authors:  R Hakkak; S Korourian; M J Ronis; J M Johnston; T M Badger
Journal:  Cancer Lett       Date:  2001-05-10       Impact factor: 8.679

5.  Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice.

Authors:  Kazuhiro Tokunaka; Naohito Ohno; Yoshiyuki Adachi; Noriko N Miura; Toshiro Yadomae
Journal:  Int Immunopharmacol       Date:  2002-01       Impact factor: 4.932

6.  Heterogeneity of chemosensitivity of esophageal and gastric carcinoma.

Authors:  Stuart J Mercer; Shaw S Somers; Louise A Knight; Pauline A Whitehouse; Sanjay Sharma; Federica Di Nicolantonio; Sharon Glaysher; Simon Toh; Ian A Cree
Journal:  Anticancer Drugs       Date:  2003-07       Impact factor: 2.248

7.  Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation.

Authors:  Hung Huynh; Thi Thanh Tuyen Nguyen; Eli Chan; Evelyne Tran
Journal:  Int J Oncol       Date:  2003-09       Impact factor: 5.650

8.  Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis.

Authors:  Jianmin Chen; Kah Poh Tan; Wendy E Ward; Lilian U Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2003-09

9.  Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.

Authors:  B U Sevin; Z L Peng; J P Perras; P Ganjei; M Penalver; H E Averette
Journal:  Gynecol Oncol       Date:  1988-09       Impact factor: 5.482

10.  Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.

Authors:  R Kuzmits; P Aiginger; M M Müller; G Steurer; W Linkesch
Journal:  Clin Sci (Lond)       Date:  1986-07       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.